Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Roberto Alcázar is active.

Publication


Featured researches published by Roberto Alcázar.


Nefrologia | 2013

Comparación de la eficacia de dos modalidades de hemodiafiltración en línea: mixta frente a posdilucional

Patricia de Sequera; Marta Albalate; Rafael Pérez-García; Elena Corchete; Marta Puerta; Mayra Ortega; Roberto Alcázar; Tamar Talaván; María J. Ruiz-Álvarez

INTRODUCTION Haemodiafiltration (HDF) with high reinfusion volumes is the most effective technique for clearing uraemic toxins. There are various modalities depending on the location where the replacement volume is administered in the extracorporeal circuit: pre-dilution, mixed or mid-dilution and post-dilution, in which the infusion is carried out pre-dilution, pre- and post-dilution simultaneously and post-dilution, respectively. OBJECTIVE Compare the clearance of small, medium-sized and protein-bound molecules and the convective volume administered in online HDF (OL-HDF) in post-dilution and mixed (pre-post-dilution) infusion. MATERIAL AND METHOD A prospective, randomised, crossover study comparing post-dilution and mixed OL-HDF. Patients (n=8) were randomly assigned to receive 6 sessions in each technique. We conducted 89 sessions, of which 68 were at a scheduled time (ST) and 21 at an effective time (ET). We determined the reduction rate (RR) percentages for various substances and the infusion volumes. The RR study was performed using ET. RESULTS The KT value obtained was greater with post-dilution OL-HDF [68 (8.1) compared to 64.9 (8.8) litres] (P=.009) when patients were dialysed at ST. This difference disappeared when dialysis was performed at ET. The difference between ST and ET was greater in mixed HDF than in post-dilution HDF [10.3 (7.4) compared to 6.5 (3.1) minutes, P=.02]. We found no differences in the RR of the substances analysed. CONCLUSION Mixed OL-HDF is not inferior to post-dilution OL-HDF either in the clearance of small and medium-sized molecules or in the clearance of protein-bound molecules at the same ET.


Nefrologia | 2010

Hemos olvidado lo más importante para prevenir las bacteriemias en pacientes portadores de catéteres para hemodiálisis

Marta Albalate; R. Pérez García; P. de Sequera; Roberto Alcázar; Marta Puerta; Mayra Ortega; A. Mossé; E. Crespo

Bacteremia associated with tunneled central venous catheters (CVC) is a major complication in hemodialysis patients. Strategies that aim to prevent catheter-related bacteremia (CRB), ranging from the application of topical antibiotics to the use of different catheter-lock solutions, have been studied, but limited interest has been shown about following standardization of aseptic care and maintenance of CVC by experienced staff. This study reports CRB incidence obtained with a strict infection prophylaxis protocol based on universal precautions against infection adopted in our Unit by qualified nursing hemodialysis staff. During a period of 20 months, 32 patients received 42 CVC. There were 2 CRB, with an incidence of 0.24 CRB/1000 days-catheter. This study shows that an optimal catheter-use management reduces the incidence of CRB to excellent rates. The use of a protocol directed to vigorously protect the catheter at the time of usage by specialized teams is critically important and is highly recommended.


Nefrologia | 2018

El dializador en el año 2017: mucho más que una membrana

Rafael Pérez-García; Roberto Alcázar

El dializador es el elemento central de la hemodiálisis, donde se producen el intercambio de sustancias entre la sangre y el líquido de diálisis (LD); la ultrafiltración (UF) y la retrofiltración. Desde las primeras diálisis con dializadores tubulares de colodión, trinitrato de celulosa, conocido como dializador de Haas, en 19241, la hemodiálisis y los dializadores han evolucionado enormemente. En esta revisión nos vamos a centrar en los cambios de los dializadores que han aparecido en las dos últimas décadas, que puede que no sean tan evidentes. Un dializador es más que una membrana, pero está claro que esta es uno de sus componentes fundamentales. Los poros de la membrana de un dializador deben ser de un tamaño determinado, numerosos y uniformes. Esto se consigue con la nanotecnología2. La formación de una capa proteica en la membrana, al ponerse en contacto con la sangre, restringe la eliminación de moléculas, modificando funcionalmente los poros3. De la aplicación de la nanotecnología van a depender varias de las especificaciones que se mencionan a continuación. El coeficiente de ultrafiltración (CUF) de un dializador es una de las características que más se valoran. El CUF y el diseño del dializador van a condicionar la retrofiltración, que no debe generar ninguna preocupación con un LD ultrapuro4, requisito imprescindible hoy en día. De hecho, es una forma de eliminar moléculas medias y grandes sin tener que recurrir a la hemodiafiltración (HDF). Un CUF alto, mayor de 40 ml/mmHg/h, es un requisito de un dializador moderno. El coeficiente de cribado (CC) debe ser alto para moléculas medias, sin pérdidas significativas de albúmina. En la hemo-


Nefrologia | 2017

Receta para prescribir fósforo durante hemodiálisis

Marta Albalate; Ma Jesús Ruiz-Alvarez; Patricia de Sequera; Rafael Pérez-García; Patricia Arribas; Elena Corchete; Caridad Ruiz Caro; Tamar Talaván Zanón; Roberto Alcázar; Mayra Ortega; Marta Puerta

The addition of phosphorus (P) to the dialysate (LD) in the form of enema Casen® is common practice in patients with hypophosphatemia. The estimation of the amount to be used and the identification of the problems that may can occur are not well defined. As a result of our work we propose a practical approach of how to proceed to increase phosphate concentration in the hemodialysate. We present a reasoned formula to calculate how much enema has to be added and the problems that may arise.


Nefrologia | 2014

Documento de la Sociedad Española de Nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica

Manuel Gorostidi; Rafael Santamaría; Roberto Alcázar; Gema Fernández-Fresnedo; Josep M. Galcerán; Marian Goicoechea; Anna Oliveras; José Portolés; Esther Rubio; Julian Segura; Pedro Aranda; M. Dolores del Pino y Pino; Francisco Fernández-Vega; José Luis Górriz; José Luño; Rafael Marín; Isabel Martínez; Luis Orte; José Carlos Rodríguez-Pérez; Mariano Rodriguez; Luis M. Ruilope


BMC Nephrology | 2015

Is it useful to increase dialysate flow rate to improve the delivered Kt

Marta Albalate; Rafael Pérez-García; Patricia de Sequera; Elena Corchete; Roberto Alcázar; Mayra Ortega; Marta Puerta


Nefrologia | 2012

La hemodiafiltración en línea mejora la respuesta al tratamiento con calcifediol

Rafael Pérez-García; Marta Albalate; Patricia de Sequera; Roberto Alcázar; Marta Puerta; Mayra Ortega; Elena Corchete


Nefrologia | 2014

Factores psicosociales y adherencia al tratamiento farmacológico en pacientes en hemodiálisis crónica

María P. Huertas-Vieco; Rafael Pérez-García; Marta Albalate; Patricia de Sequera; Mayra Ortega; Marta Puerta; Elena Corchete; Roberto Alcázar


Nefrologia | 2013

Set-point de sodio en hemodiálisis: ¿es lo que vemos en la clínica?

Marta Albalate; Patricia de Sequera; Rafael Pérez-García; María J. Ruiz-Álvarez; Elena Corchete; Tamar Talaván; Roberto Alcázar; Marta Puerta; Mayra Ortega-Díaz


Nefrologia | 2012

Conocimiento y aplicación en la práctica real del Documento de consenso S.E.N.-semFYC sobre la enfermedad renal crónica

M. Isabel Egocheaga; Roberto Alcázar; José M. Lobos; J. Luis Górriz; Alberto Martínez-Castelao; Ana Pastor; Isabel Martínez; Fernando Caballero; Marta Sánchez-Celaya

Collaboration


Dive into the Roberto Alcázar's collaboration.

Top Co-Authors

Avatar

Marta Albalate

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Patricia de Sequera

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Alberto Tejedor

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

José Carlos Rodríguez-Pérez

University of Las Palmas de Gran Canaria

View shared research outputs
Top Co-Authors

Avatar

Julian Segura

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Luis M. Ruilope

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Marian Goicoechea

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

María P. Huertas-Vieco

Complutense University of Madrid

View shared research outputs
Researchain Logo
Decentralizing Knowledge